CD146
CD146 also known as Melanoma Cell Adhesion Molecule (MCAM) or Cell surface glycoprotein MUC18, is a protein that in humans is encoded by the MCAM gene. CD146 plays a role in cell adhesion, and in cohesion of the endothelial monolayer at intercellular junctions in vascular tissue. As a cell adhesion molecule, CD146 plays a role in the interaction of activated endothelial cells with leukocytes, monocytes, and lymphocytes.
Structure[edit]
The CD146 protein is a member of the immunoglobulin superfamily, with a structure similar to that of the neural cell adhesion molecule. The protein is believed to be involved in cell-cell interactions or cell-substrate interactions. It is also thought to play a role in the process of angiogenesis, the formation of new blood vessels from pre-existing vessels.
Function[edit]
CD146 is involved in a variety of biological processes. It is involved in the adhesion and migration of cells, and also in the organization of cells into tissues. It is also involved in the process of angiogenesis, the formation of new blood vessels from pre-existing vessels. CD146 is also thought to play a role in the immune response, as it is involved in the interaction of activated endothelial cells with leukocytes, monocytes, and lymphocytes.
Clinical significance[edit]
CD146 has been found to be overexpressed in several types of cancer, including melanoma, breast cancer, and prostate cancer. It is thought that the overexpression of CD146 may contribute to the aggressive behavior of these cancers. CD146 is also thought to play a role in the development of cardiovascular disease, as it is involved in the formation of new blood vessels, a process that is often dysregulated in cardiovascular disease.
See also[edit]
- Cell adhesion
- Endothelial cells
- Leukocytes
- Monocytes
- Lymphocytes
- Angiogenesis
- Melanoma
- Breast cancer
- Prostate cancer
- Cardiovascular disease
References[edit]
<references />
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian


